Real-world evidence (RWE) is used in an exponential way to guide payment decisions and access systems for patients and help clinical decision-making in conditions such as cancer characterized by heterogeneous patient groups and different care routes. https://www.delveinsight.com/whitepaper-newsletter/real-world-evidence-diagnostics-in-cancer

1. 1
The Real-World Evidence Whitepaper
Real-world evidence (RWE) is used in an exponential way to guide payment decisions and access
systems for #patients and help #clinical decision-making in conditions such as cancer characterized
by heterogeneous patient groups and different care routes.
In the world of cancer #diagnostics, RWE draws from a range of sources, including electronic
health #reports, customer #data, payer #claims databases, patient registries, and others, allowing

2. 2
innovators to explain how a product can work over sometime within a larger, more representative
population. Interest in real-world evidence in the pharmaceutical industry continues to grow due to
regulatory opportunities and payer demands.
Want to learn more about the need and importance of Real-world evidence in today’s cancer
diagnostics era?
Access here for free:- https://lnkd.in/gQpCVFP
Source:- https://www.delveinsight.com/whitepaper-newsletter/real-world-evidence-
diagnostics-in-cancer
#healthcare #digitalhealth #healthtech #medtech #clinicaltrials #medicaldevices #research #bi
otech #data #health #opportunities #pharmaceuticalindustry #diagnostics #cancer #medicine
#work